Cargando…
The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India
BACKGROUND: Tuberculosis (TB) is a major cause of death globally. India carries the highest share of the global TB burden. The COVID-19 pandemic has severely impacted diagnosis of TB in India, yet there is limited data on how TB case reporting has changed since the pandemic began and which factors d...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792515/ https://www.ncbi.nlm.nih.gov/pubmed/35086472 http://dx.doi.org/10.1186/s12879-022-07078-y |
_version_ | 1784640379209908224 |
---|---|
author | Arentz, Matthew Ma, Jianing Zheng, Peng Vos, Theo Murray, Christopher J. L. Kyu, Hmwe H. |
author_facet | Arentz, Matthew Ma, Jianing Zheng, Peng Vos, Theo Murray, Christopher J. L. Kyu, Hmwe H. |
author_sort | Arentz, Matthew |
collection | PubMed |
description | BACKGROUND: Tuberculosis (TB) is a major cause of death globally. India carries the highest share of the global TB burden. The COVID-19 pandemic has severely impacted diagnosis of TB in India, yet there is limited data on how TB case reporting has changed since the pandemic began and which factors determine differences in case notification. METHODS: We utilized publicly available data on TB case reporting through the Indian Central TB Division from January 2017 through April of 2021 (prior to the first COVID-19 related lockdown). Using a Poisson model, we estimated seasonal and yearly patterns in TB case notification in India from January 2017 through February 2020 and extended this estimate as the counterfactual expected TB cases notified from March 2020 through April 2021. We characterized the differences in case notification observed and those expected in the absence of the pandemic by State and Territory. We then performed a linear regression to examine the relationship between the logit ratio of reported TB to counterfactual cases and mask use, mobility, daily hospitalizations/100,000 population, and public/total TB case reporting. RESULTS: We found 1,320,203 expected cases of TB (95% uncertainty interval (UI) 1,309,612 to 1,330,693) were not reported during the period from March 2020 through April 2021. This represents a 63.3% difference (95% UI 62.8 to 63.8) in reporting. We found that mobility data and average hospital admissions per month per population were correlated with differences in TB case notification, compared to the counterfactual in the absence of the pandemic (p > 0.001). CONCLUSION: There was a large difference between reported TB cases in India and those expected in the absence of the pandemic. This information can help inform the Indian TB program as they consider interventions to accelerate case finding and notification once the pandemic related TB service disruptions improve. Mobility data and hospital admissions are surrogate measures that correlate with a greater difference in reported/expected TB cases and may correlate with a disruption in TB diagnostic services. However, further research is needed to clarify this association and identify other key contributors to gaps in TB case notifications in India. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07078-y. |
format | Online Article Text |
id | pubmed-8792515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87925152022-01-27 The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India Arentz, Matthew Ma, Jianing Zheng, Peng Vos, Theo Murray, Christopher J. L. Kyu, Hmwe H. BMC Infect Dis Research BACKGROUND: Tuberculosis (TB) is a major cause of death globally. India carries the highest share of the global TB burden. The COVID-19 pandemic has severely impacted diagnosis of TB in India, yet there is limited data on how TB case reporting has changed since the pandemic began and which factors determine differences in case notification. METHODS: We utilized publicly available data on TB case reporting through the Indian Central TB Division from January 2017 through April of 2021 (prior to the first COVID-19 related lockdown). Using a Poisson model, we estimated seasonal and yearly patterns in TB case notification in India from January 2017 through February 2020 and extended this estimate as the counterfactual expected TB cases notified from March 2020 through April 2021. We characterized the differences in case notification observed and those expected in the absence of the pandemic by State and Territory. We then performed a linear regression to examine the relationship between the logit ratio of reported TB to counterfactual cases and mask use, mobility, daily hospitalizations/100,000 population, and public/total TB case reporting. RESULTS: We found 1,320,203 expected cases of TB (95% uncertainty interval (UI) 1,309,612 to 1,330,693) were not reported during the period from March 2020 through April 2021. This represents a 63.3% difference (95% UI 62.8 to 63.8) in reporting. We found that mobility data and average hospital admissions per month per population were correlated with differences in TB case notification, compared to the counterfactual in the absence of the pandemic (p > 0.001). CONCLUSION: There was a large difference between reported TB cases in India and those expected in the absence of the pandemic. This information can help inform the Indian TB program as they consider interventions to accelerate case finding and notification once the pandemic related TB service disruptions improve. Mobility data and hospital admissions are surrogate measures that correlate with a greater difference in reported/expected TB cases and may correlate with a disruption in TB diagnostic services. However, further research is needed to clarify this association and identify other key contributors to gaps in TB case notifications in India. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07078-y. BioMed Central 2022-01-27 /pmc/articles/PMC8792515/ /pubmed/35086472 http://dx.doi.org/10.1186/s12879-022-07078-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Arentz, Matthew Ma, Jianing Zheng, Peng Vos, Theo Murray, Christopher J. L. Kyu, Hmwe H. The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India |
title | The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India |
title_full | The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India |
title_fullStr | The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India |
title_full_unstemmed | The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India |
title_short | The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India |
title_sort | impact of the covid-19 pandemic and associated suppression measures on the burden of tuberculosis in india |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792515/ https://www.ncbi.nlm.nih.gov/pubmed/35086472 http://dx.doi.org/10.1186/s12879-022-07078-y |
work_keys_str_mv | AT arentzmatthew theimpactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT majianing theimpactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT zhengpeng theimpactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT vostheo theimpactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT murraychristopherjl theimpactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT kyuhmweh theimpactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT arentzmatthew impactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT majianing impactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT zhengpeng impactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT vostheo impactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT murraychristopherjl impactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia AT kyuhmweh impactofthecovid19pandemicandassociatedsuppressionmeasuresontheburdenoftuberculosisinindia |